NEPHROS INC (NEPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5M 5M 7.5M Q3 '21: 2.6M Q4 '21: 2.7M Q1 '22: 2.2M Q2 '22: 2.9M Q3 '22: 2.4M Q4 '22: 2.6M Q1 '23: 3.7M Q2 '23: 3.5M Q3 '23: 3.7M Q4 '23: 3.3M Q1 '24: 3.5M Q2 '24: 3.3M Q3 '24: 3.5M Q4 '24: 3.9M Q1 '25: 4.9M Q2 '25: 4.4M Q3 '25: 4.8M Q4 '25: 4.7M Q1 '26: 5.2M Q2 '26: 6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 1.5M 3M 4.5M Q3 '21: 1.4M Q4 '21: 1.5M Q1 '22: 1.1M Q2 '22: 1.4M Q3 '22: 762K Q4 '22: 1.5M Q1 '23: 2.1M Q2 '23: 2.1M Q3 '23: 2.2M Q4 '23: 2M Q1 '24: 2.2M Q2 '24: 1.9M Q3 '24: 2.1M Q4 '24: 2.5M Q1 '25: 3.2M Q2 '25: 2.8M Q3 '25: 2.9M Q4 '25: 2.8M Q1 '26: 3M Q2 '26: 4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -802K Q4 '21: -721K Q1 '22: -1.5M Q2 '22: -814K Q3 '22: -1.3M Q4 '22: -693K Q1 '23: -306K Q2 '23: -435K Q3 '23: -203K Q4 '23: -649K Q1 '24: -200K Q2 '24: -317K Q3 '24: 206K Q4 '24: 317K Q1 '25: 566K Q2 '25: 248K Q3 '25: 314K Q4 '25: 18K Q1 '26: 97K Q2 '26: 1.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -1.2M Q4 '21: -863K Q1 '22: -2M Q2 '22: -1.1M Q3 '22: -3.2M Q4 '22: -848K Q1 '23: -306K Q2 '23: -433K Q3 '23: -182K Q4 '23: -654K Q1 '24: -169K Q2 '24: -289K Q3 '24: 183K Q4 '24: 349K Q1 '25: 558K Q2 '25: 237K Q3 '25: 337K Q4 '25: 62K Q1 '26: 140K Q2 '26: 1.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 800K 1.6M 2.4M Q3 '21: 1.2M Q4 '21: 1.2M Q1 '22: 1.1M Q2 '22: 1.5M Q3 '22: 1.6M Q4 '22: 1M Q1 '23: 1.6M Q2 '23: 1.5M Q3 '23: 1.5M Q4 '23: 1.2M Q1 '24: 1.3M Q2 '24: 1.3M Q3 '24: 1.4M Q4 '24: 1.4M Q1 '25: 1.7M Q2 '25: 1.6M Q3 '25: 1.8M Q4 '25: 2M Q1 '26: 2.2M Q2 '26: 2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q2 '21: -117K Q3 '21: -910K Q4 '21: -335K Q1 '22: -1.8M Q2 '22: -1.1M Q3 '22: -170K Q4 '22: -195K Q1 '23: 276K Q2 '23: 226K Q3 '23: 562K Q1 '24: -672K Q2 '24: -501K Q3 '24: -623K Q4 '24: 1.3M Q1 '25: 322K Q2 '25: 994K Q3 '25: 99K Q4 '25: 230K Q1 '26: -1.7M Q2 '26: 681K Q3 '21 Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q4 '10: -675K Q3 '12: -717K Q4 '12: -459K Q1 '16: -548K Q2 '16: -286K Q3 '16: -795K Q4 '16: -528K Q4 '19: 364K Q3 '20: -1.8M Q4 '20: -1.5M Q1 '21: -78K Q2 '21: -117K Q3 '21: -923K Q4 '21: -335K Q1 '22: -1.8M Q2 '22: -1.2M Q3 '22: -170K Q4 '22: -195K Q3 '24: -623K Q4 '24: 1.3M Q3 '12 Q2 '16 Q4 '19 Q1 '21 Q4 '21 Q3 '22 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '15: 32.6M Q1 '16: 48.2M Q2 '16: 48.5M Q1 '21: 9.9M Q2 '21: 9.9M Q3 '21: 10M Q1 '22: 10.2M Q2 '22: 10.3M Q3 '22: 10.3M Q1 '23: 10.3M Q2 '23: 10.3M Q3 '23: 10.5M Q1 '24: 10.5M Q2 '24: 10.5M Q3 '24: 10.6M Q1 '25: 10.6M Q2 '25: 10.8M Q3 '25: 11M Q1 '26: 11M Q2 '26: 11.1M Q1 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q3 '21: -0.38 Q4 '21: -0.41 Q1 '22: -0.55 Q2 '22: -0.55 Q3 '22: -0.74 Q4 '22: -0.73 Q1 '23: -0.56 Q2 '23: -0.48 Q3 '23: -0.19 Q4 '23: -0.15 Q1 '24: -0.14 Q2 '24: -0.13 Q3 '24: -0.09 Q4 '24: 0.01 Q1 '25: 0.08 Q2 '25: 0.13 Q3 '25: 0.14 Q4 '25: 0.11 Q1 '26: 0.07 Q2 '26: 0.16 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.